Skip to content
Clinical Trials for Alzheimer's Disease

Baltimore, Maryland

Alzheimer's disease clinical trials in Baltimore, MD

12 Alzheimer's disease studies are recruiting participants at sites in Baltimore as of November 16, 2026, according to ClinicalTrials.gov. Clinical Trials for Alzheimer's Disease can help you understand your options and connect with a study team.

Call (888) 927-5895
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Baltimore at a glance

  • 12 studies are recruiting at a site in Baltimore.
  • By phase: Early Phase 1 (1), Phase 2 (3), Phase 3 (1), No phase (4), Observational (3). Studies of devices and behavioral approaches have no phase.
  • By sponsor: university, hospital or other (8), government (3), industry (1).
  • Most recent update to one of these records: November 16, 2026.

Studies recruiting in Baltimore

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. PET Imaging in the Baltimore Longitudinal Study of Aging (BLSA)

    • Observational
    • Ages 55 to 110
    • All sexes
    Sponsor
    National Institute on Aging (NIA)
    Study site
    National Institute of Aging, Clinical Research Unit
    Registry record
    NCT07099053 · updated
  2. Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin

    • Phase 2
    • Ages 65 to 120
    • All sexes
    Sponsor
    National Institute on Aging (NIA)
    Study site
    National Institute of Aging, Clinical Research Unit
    Registry record
    NCT07721467 · updated
  3. HEARS-NPS: Addressing Hearing Loss as a Common Unmet Contributor of Neuropsychiatric Symptoms

    • No phase
    • Ages 60 to 100
    • All sexes
    Sponsor
    Johns Hopkins University
    Study site
    Johns Hopkins Memory and Alzheimer's Treatment Center
    Registry record
    NCT06930560 · updated
  4. Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease

    • Early Phase 1
    • Ages 18 to 85
    • All sexes
    Sponsor
    Johns Hopkins University
    Study site
    Johns Hopkins Center for Psychedelic and Consciousness Research
    Registry record
    NCT04123314 · updated
  5. Global Blood-Brain Barrier Disruption and Post-Stroke Cognitive Decline

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    Johns Hopkins University
    Study site
    Johns Hopkins Hospital
    Registry record
    NCT05556395 · updated
  6. Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    Eidos Therapeutics, a BridgeBio company
    Study sites
    Johns Hopkins University · University of Maryland Medical Center
    Registry record
    NCT06563895 · updated
  7. Trial of CORT108297 to Attenuate the Effects of Acute Stress in the Allocortex (CORT-X)

    • Phase 2
    • Ages 55 and older
    • All sexes
    Sponsor
    Johns Hopkins University
    Study site
    Johns Hopkins School of Medicine
    Registry record
    NCT04601038 · updated
  8. Targeting Cognition in Early Alzheimer's Disease by Improving Sleep With Trazodone

    • Phase 2
    • Ages 55 and older
    • All sexes
    Sponsor
    Johns Hopkins University
    Study site
    Johns Hopkins Hospital
    Registry record
    NCT05282550 · updated
  9. Music Therapy for Patients With Alzheimer's Disease

    • No phase
    • Ages 18 to 89
    • All sexes
    Sponsor
    Johns Hopkins University
    Study site
    Johns Hopkins School of Medicine
    Registry record
    NCT05151562 · updated
  10. Cognitive Vulnerability to Stress in Individuals at Risk for Alzheimer's Disease

    • No phase
    • Ages 60 and older
    • All sexes
    Sponsor
    Johns Hopkins University
    Study site
    Johns Hopkins School of Medicine
    Registry record
    NCT05795634 · updated
  11. Vestibular Therapy in Alzheimer's Disease

    • No phase
    • Ages 60 and older
    • All sexes
    Sponsor
    Johns Hopkins University
    Study site
    Johns Hopkins University School of Medicine
    Registry record
    NCT03799991 · updated
  12. Medicare Anti-Aβ mAb Coverage With Evidence Development (CED) Study

    • Observational
    • All ages
    • All sexes
    Sponsor
    Centers for Medicare and Medicaid Services/ Coverage and Analysis Group
    Study site
    Centers for Medicare and Medicaid Services
    Registry record
    NCT06058234 · updated

Source: ClinicalTrials.gov. Data processed . See every Alzheimer's disease study recruiting in Baltimore, MD on ClinicalTrials.gov.

Ask about studies near Baltimore

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Clinical Trials for Alzheimer's Disease does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-5895

or send a short form

How should we reach you?

Call